Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 31
Filtrar
2.
Environ Monit Assess ; 196(4): 369, 2024 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-38489113

RESUMEN

Protected areas are typically managed as a network of sites exposed to varying anthropogenic conditions. Managing these networks benefits from monitoring of conditions across sites to help prioritize coordinated efforts. Monitoring marine vessel activity and related underwater radiated noise impacts across a network of protected areas, like the U.S. National Marine Sanctuary system, helps managers ensure the quality of habitats used by a wide range of marine species. Here, we use underwater acoustic detections of vessels to quantify different characteristics of vessel noise at 25 locations within eight marine sanctuaries including the Hawaiian Archipelago and the U.S. east and west coasts. Vessel noise metrics, including temporal presence and sound levels, were paired with Automatic Identification System (AIS) vessel tracking data to derive a suite of robust vessel noise indicators for use across the network of marine protected areas. Network-wide comparisons revealed a spectrum of vessel noise conditions that closely matched AIS vessel traffic composition. Shifts in vessel noise were correlated with the decrease in vessel activity early in the COVID-19 pandemic, and vessel speed reduction management initiatives. Improving our understanding of vessel noise conditions in these protected areas can help direct opportunities for reducing vessel noise, such as establishing and maintaining noise-free periods, enhancing port efficiency, engaging with regional and international vessel quieting initiatives, and leveraging co-benefits of management actions for reducing ocean noise.


Asunto(s)
Pandemias , Navíos , Humanos , Monitoreo del Ambiente , Ruido , Acústica , Ecosistema
3.
Transplant Cell Ther ; 30(2): 191-202, 2024 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-37967650

RESUMEN

Chimeric antigen receptor T cell (CAR-T) therapy has shown rapid, frequent, and deep responses in patients with relapsed/refractory multiple myeloma (RRMM). However, relapse frequently occurs following CAR-T therapy, and the cause of this resistance is not well defined. Among the potential mechanisms of resistance, T cell intrinsic factors may be an important source of failure. Here we used spectral flow cytometry to identify the changes in T cell phenotypes in bone marrow aspirates at different stages of multiple myeloma progression, including cases that relapsed after anti-BCMA CAR-T therapy. We identified completely different T cell phenotypes in RRMM and post CAR-T relapse cases compared to healthy donors and earlier stages of multiple myeloma, novel double-negative CD3+ T cells in RRMM and CAR-T relapsed cases, and differences in CD8 T cell phenotype at the baseline between peripheral blood and bone marrow from healthy donors. We found that the majority of T cells in RRMM patients and significant T cell subsets in post-CAR-T relapsed patients expressed multiple coinhibitory markers, including PD1, TIGIT, 2B4, and KLRG1.


Asunto(s)
Mieloma Múltiple , Receptores Quiméricos de Antígenos , Humanos , Mieloma Múltiple/terapia , Antígeno de Maduración de Linfocitos B/genética , Recurrencia Local de Neoplasia , Recurrencia , Tratamiento Basado en Trasplante de Células y Tejidos , Receptores Inmunológicos , Lectinas Tipo C
4.
Synthesis (Stuttg) ; 55(15): 2319-2324, 2023 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-37691879

RESUMEN

A new method to prepare 1,4-oxazinone intermediates was developed based on aza-conjugate addition of ß-amino alcohols to electron-deficient alkyne precursors. A tandem intramolecular cycloaddition/cycloreversion reaction sequence was evaluated, leading to the synthesis of the guaipyridine alkaloid natural products rupestine M and L. Starting from (-)-citronellal and thus a known configuration of the C5 stereocenter, a revised absolute configuration of natural rupestine L is suggested based on optical rotation.

5.
J Acoust Soc Am ; 153(3): 1710, 2023 03.
Artículo en Inglés | MEDLINE | ID: mdl-37002102

RESUMEN

Marine soundscapes provide the opportunity to non-invasively learn about, monitor, and conserve ecosystems. Some fishes produce sound in chorus, often in association with mating, and there is much to learn about fish choruses and the species producing them. Manually analyzing years of acoustic data is increasingly unfeasible, and is especially challenging with fish chorus, as multiple fish choruses can co-occur in time and frequency and can overlap with vessel noise and other transient sounds. This study proposes an unsupervised automated method, called SoundScape Learning (SSL), to separate fish chorus from soundscape using an integrated technique that makes use of randomized robust principal component analysis (RRPCA), unsupervised clustering, and a neural network. SSL was applied to 14 recording locations off southern and central California and was able to detect a single fish chorus of interest in 5.3 yrs of acoustically diverse soundscapes. Through application of SSL, the chorus of interest was found to be nocturnal, increased in intensity at sunset and sunrise, and was seasonally present from late Spring to late Fall. Further application of SSL will improve understanding of fish behavior, essential habitat, species distribution, and potential human and climate change impacts, and thus allow for protection of vulnerable fish species.


Asunto(s)
Ecosistema , Sonido , Animales , Acústica , Peces , Ruido
6.
Cell Biochem Biophys ; 81(1): 151-160, 2023 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-36251137

RESUMEN

ATP-binding cassette transporter A-I (ABCA1) is an ubiquitously expressed protein whose main function is the transmembrane transport of cholesterol and phospholipids. Synthesis of ABCA1 protein in liver is necessary for high-density lipoprotein (HDL) formation in mammals. Thus, the mechanism of ABCA1 gene expression regulation in hepatocytes are of critical importance. Recently, we have found the insulin-dependent downregulation of other key player in the HDL formation-apolipoprotein A-I gene (J. Cell. Biochem., 2017, 118:382-396). Nothing is known about the role of insulin in the regulation of ABCA1 gene. Here we show for the first time that insulin decreases the mRNA and protein levels of ABCA1 in human hepatoma cell line HepG2. PI3K, p38, MEK1/2, JNK and mTORC1 signaling pathways are involved in the insulin-mediated downregulation of human ABCA1 gene. Transcription factors LXRα, LXRß, FOXO1 and NF-κB are important contributors to this process, while FOXA2 does not regulate ABCA1 gene expression. Insulin causes the decrease in FOXO1, LXRα and LXRß binding to ABCA1 promoter, which is likely the cause of the decrease in the gene expression. Interestingly, the murine ABCA1 gene seems to be not regulated by insulin in hepatocytes (in vitro and in vivo). We suggest that the reason for this discrepancy is the difference in the 5'-regulatory regions of human and murine ABCA1 genes.


Asunto(s)
Transportador 1 de Casete de Unión a ATP , Insulina , Receptores X del Hígado , Receptores Nucleares Huérfanos , Animales , Humanos , Ratones , Transportador 1 de Casete de Unión a ATP/genética , Carcinoma Hepatocelular , Línea Celular , Proteína Forkhead Box O1/genética , Proteína Forkhead Box O1/metabolismo , Insulina/metabolismo , Neoplasias Hepáticas , Receptores X del Hígado/genética , Receptores X del Hígado/metabolismo , Mamíferos/metabolismo , Receptores Nucleares Huérfanos/genética , Receptores Nucleares Huérfanos/metabolismo
8.
Biochemistry (Mosc) ; 87(11): 1252-1259, 2022 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-36509728

RESUMEN

Adiponectin is an adipose tissue hormone, participating in energy metabolism and involved in atherogenesis. Previously, it was found that adiponectin increases expression of the APOA1 (apolipoprotein A-1) gene in hepatocytes, but the mechanisms of this effect remained unexplored. Our aim was to investigate the role of adiponectin receptors AdipoR1/R2, AMP-activated protein kinase (AMPK), nuclear peroxisome proliferator-activated receptor alpha (PPARα) and liver X receptors (LXRs) in mediating the action of adiponectin on hepatic APOA1 expression in human hepatoma HepG2 cells. The level of APOA1 expression was determined by RT-qPCR and ELISA. We showed that the siRNA-mediated knockdown of genes coding for AdipoR1, AdipoR2, AMPK, PPARα, and LXRα and ß prevented adiponectin-induced APOA1 expression in HepG2 cells and demonstrated that interaction of PPARα and LXRs with the APOA1 gene hepatic enhancer is important for the adiponectin-dependent APOA1 transcription. The results of this study point out to the involvement of both types of adiponectin receptors, AMPK, PPARα, and LXRs in the adiponectin-dependent upregulation of the APOA1 expression.


Asunto(s)
Adiponectina , PPAR alfa , Humanos , PPAR alfa/genética , PPAR alfa/metabolismo , Adiponectina/genética , Adiponectina/metabolismo , Receptores X del Hígado/genética , Receptores de Adiponectina/genética , Receptores de Adiponectina/metabolismo , Células Hep G2 , Apolipoproteína A-I/genética , Proteínas Quinasas Activadas por AMP/metabolismo , Expresión Génica
9.
European J Org Chem ; 2022(17): e202101278, 2022 May 06.
Artículo en Inglés | MEDLINE | ID: mdl-35910459

RESUMEN

Teraryl-based α-helix mimetics have proven to be useful compounds for the inhibition of protein-protein interactions (PPI). We have developed a modular and flexible approach for the synthesis of teraryl-based α-helix mimetics using a benzene core unit featuring two leaving groups of differentiated reactivity in the Pd-catalyzed cross-coupling used for teraryl assembly. In previous publications we have introduced the methodology of 4-iodophenyltriflates decorated with the side chains of some of the proteinogenic amino acids. We herein report the core fragments corresponding to the previously missing amino acids Arg, Asn, Asp, Met, Trp and Tyr. Therefore, our set now encompasses all relevant amino acid analogues with the exception of His. In order to be compatible with the triflate moiety, some of the nucleophilic side chains had to be provided in a protected form to serve as stable building blocks. Additionally, cross-coupling procedures for the assembly of teraryls were investigated.

10.
Expert Opin Ther Targets ; 25(3): 167-174, 2021 03.
Artículo en Inglés | MEDLINE | ID: mdl-33703985

RESUMEN

INTRODUCTION: KRAS mutations drive tumorigenesis by altering cell signaling and the tumor immune microenvironment. Recent studies have shown promise for KRAS-G12C covalent inhibitors, which are advancing rapidly through clinical trials. The sequencing and combination of these agents with other therapies including immune checkpoint blockade (ICB) will benefit from strategies that also address the immune microenvironment to improve durability of response. AREAS COVERED: This paper reviews KRAS signaling and discusses downstream effects on cytokine production and the tumor immune microenvironment. RAS targeted therapy is introduced and perspectives on therapeutic targeting of KRAS-G12C and its immunosuppressive tumor microenvironment are offered. EXPERT OPINION: The availability of KRAS-G12C covalent inhibitors raises hopes for targeting this pervasive oncogene and designing better therapeutic combinations to promote anti-tumor immunity. A comprehensive mechanistic understanding of KRAS immunosuppression is required in order to prioritize agents for clinical trials.


Asunto(s)
Antineoplásicos/farmacología , Neoplasias/tratamiento farmacológico , Proteínas Proto-Oncogénicas p21(ras)/antagonistas & inhibidores , Animales , Antineoplásicos/administración & dosificación , Diseño de Fármacos , Humanos , Inhibidores de Puntos de Control Inmunológico/administración & dosificación , Inhibidores de Puntos de Control Inmunológico/farmacología , Inmunidad Innata , Terapia Molecular Dirigida , Mutación , Neoplasias/genética , Neoplasias/inmunología , Proteínas Proto-Oncogénicas p21(ras)/genética , Microambiente Tumoral/inmunología
11.
J Stomatol Oral Maxillofac Surg ; 119(6): 486-488, 2018 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-29936238

RESUMEN

Dental extraction is one of the acts that cannot be undertaken or carried out without total analgesia. Unfortunately, the success of anesthesia is not always systematic. Failures are noted during the extraction of mandibular wisdom teeth and pain management therefore remains a challenge for their extraction. The anesthesia technique and nature of the adapted anesthetic solution are controversial. However, the most commonly used technique is the Lower Alveolar Nerve Block (IANB). This technique has disadvantages (trismus, risk of intra-arterial injection and hematoma) and a failure rate of up to 88%. In some survey, 90% of 93 practitioners had difficulty obtaining proper anesthesia. Other clinical studies have also shown overall failure rates of 37%-47%, and 15%-35% on healthy lower molars. Recent studies have evaluated the success rate of articaine at between 54% and 94%, while others have shown that for mandibular teeth, articaine is more effective in para-apical anesthesia than lidocaine. Sixty subjects were selected for the study. The aim was to evaluate the overall success rate of first intention 4% articaine para-apical anesthesia during extraction of third mandibular molars. The overall success rate of para-apical anesthesia was 87%.


Asunto(s)
Carticaína , Tercer Molar , Anestésicos Locales , Nervio Mandibular , Diente Molar
12.
Eur J Cell Biol ; 97(3): 204-215, 2018 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-29550264

RESUMEN

C3 is an acute phase protein, and thus its plasma concentration increases quickly and drastically during the onset of inflammation. Insulin plays a complex role in inflammation. Elevated level of plasma C3 was shown to correlate with heightened fasting insulin levels and insulin resistance and appears to be a risk factor for the cardiovascular disease and atherosclerosis. The main source of plasma C3 is liver. Nothing is known about effects of insulin on C3 gene expression and protein secretion by hepatocytes. In light of these data we asked if insulin is capable of regulating C3 production in hepatocytes. Here we show that insulin downregulates C3 gene expression in human hepatoma cells HepG2 through activation of PI3K, mTORC1, p38 and MEK1/2 signaling pathways. Transcription factors PPARα, PPARγ, HNF4α and NF-κB are important contributors to this process. Insulin activates PPARγ through PI3K/Akt/mTORC1 pathway, which results in PPARγ binding to DR4 and DR0 cis-acting elements within the C3 promoter and subsequent displacement of HNF4α and PPARα from these sites. As a result PPARα/NF-κB complex, which exists on C3 promoter, is broken down and C3 gene expression is downregulated. The data obtained can potentially be used to explain the molecular mechanism underlying the correlation between heightened level of plasma C3 and insulin resistance in humans.


Asunto(s)
Complemento C3/biosíntesis , Regulación de la Expresión Génica/fisiología , Hepatocitos/metabolismo , Insulina/metabolismo , PPAR gamma/metabolismo , Animales , Complemento C3/genética , Regulación hacia Abajo , Células Hep G2 , Humanos , Ratones , Ratones Endogámicos C57BL , Regiones Promotoras Genéticas , Transducción de Señal/fisiología
13.
Mol Cell Biochem ; 448(1-2): 211-223, 2018 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-29442267

RESUMEN

Apolipoprotein A-I (ApoA-I) is the main structural and functional protein component of high-density lipoprotein. ApoA-I has been shown to regulate lipid metabolism and inflammation in macrophages. Recently, we found the moderate expression of endogenous apoA-I in human monocytes and macrophages and showed that pro-inflammatory cytokine tumor necrosis factor α (TNFα) increases apoA-I mRNA and stimulates ApoA-I protein secretion by human monocytes and macrophages. Here, we present data about molecular mechanisms responsible for the TNFα-mediated activation of apoA-I gene in human monocytes and macrophages. This activation depends on JNK and MEK1/2 signaling pathways in human monocytes, whereas inhibition of NFκB, JNK, or p38 blocks an increase of apoA-I gene expression in the macrophages treated with TNFα. Nuclear receptor PPARα is a ligand-dependent regulator of apoA-I gene, whereas LXRs stimulate apoA-I mRNA transcription and ApoA-I protein synthesis and secretion by macrophages. Treatment of human macrophages with PPARα or LXR synthetic ligands as well as knock-down of LXRα, and LXRß by siRNAs interfered with the TNFα-mediated activation of apoA-I gene in human monocytes and macrophages. At the same time, TNFα differently regulated the levels of PPARα, LXRα, and LXRß binding to the apoA-I gene promoter in THP-1 cells. Obtained results suggest a novel tissue-specific mechanism of the TNFα-mediated regulation of apoA-I gene in monocytes and macrophages and show that endogenous ApoA-I might be positively regulated in macrophage during inflammation.


Asunto(s)
Apolipoproteína A-I/biosíntesis , Quinasas MAP Reguladas por Señal Extracelular/metabolismo , Regulación de la Expresión Génica , Receptores X del Hígado/metabolismo , Macrófagos/metabolismo , Monocitos/metabolismo , FN-kappa B/metabolismo , PPAR alfa/metabolismo , Factor de Necrosis Tumoral alfa/metabolismo , Humanos , Macrófagos/citología , Monocitos/citología , Células THP-1
14.
J Cell Biochem ; 118(2): 382-396, 2017 02.
Artículo en Inglés | MEDLINE | ID: mdl-27404023

RESUMEN

Apolipoprotein A-I (ApoA-I) is a key component of high density lipoproteins which possess anti-atherosclerotic and anti-inflammatory properties. Insulin is a crucial mediator of the glucose and lipid metabolism that has been implicated in atherosclerotic and inflammatory processes. Important mediators of insulin signaling such as Liver X Receptors (LXRs) and Forkhead Box A2 (FOXA2) are known to regulate apoA-I expression in liver. Forkhead Box O1 (FOXO1) is a well-known target of insulin signaling and a key mediator of oxidative stress response. Low doses of insulin were shown to activate apoA-I expression in human hepatoma HepG2 cells. However, the detailed mechanisms for these processes are still unknown. We studied the possible involvement of FOXO1, FOXA2, LXRα, and LXRß transcription factors in the insulin-mediated regulation of apoA-I expression. Treatment of HepG2 cells with high doses of insulin (48 h, 100 nM) suppresses apoA-I gene expression. siRNAs against FOXO1, FOXA2, LXRß, or LXRα abrogated this effect. FOXO1 forms a complex with LXRß and insulin treatment impairs FOXO1/LXRß complex binding to hepatic enhancer and triggers its nuclear export. Insulin as well as LXR ligand TO901317 enhance the interaction between FOXA2, LXRα, and hepatic enhancer. These data suggest that high doses of insulin downregulate apoA-I gene expression in HepG2 cells through redistribution of FOXO1/LXRß complex, FOXA2, and LXRα on hepatic enhancer of apoA-I gene. J. Cell. Biochem. 118: 382-396, 2017. © 2016 Wiley Periodicals, Inc.


Asunto(s)
Apolipoproteína A-I/biosíntesis , Carcinoma Hepatocelular/metabolismo , Regulación hacia Abajo/efectos de los fármacos , Proteína Forkhead Box O1/metabolismo , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Insulina/farmacología , Neoplasias Hepáticas/metabolismo , Receptores X del Hígado/metabolismo , Proteínas de Neoplasias/metabolismo , Carcinoma Hepatocelular/patología , Células Hep G2 , Humanos , Hidrocarburos Fluorados/farmacología , Neoplasias Hepáticas/patología , Sulfonamidas/farmacología
15.
Cell Stress Chaperones ; 22(1): 123-134, 2017 01.
Artículo en Inglés | MEDLINE | ID: mdl-27896567

RESUMEN

Reactive oxygen species damage various cell components including DNA, proteins, and lipids, and these impairments could be a reason for severe human diseases including atherosclerosis. Forkhead box O1 (FOXO1), an important metabolic transcription factor, upregulates antioxidant and proapoptotic genes during oxidative stress. Apolipoprotein A-I (ApoA-I) forms high density lipoprotein (HDL) particles that are responsible for cholesterol transfer from peripheral tissues to liver for removal in bile in vertebrates. The main sources for plasma ApoA-I in mammals are liver and jejunum. Hepatic apoA-I transcription depends on a multitude of metabolic transcription factors. We demonstrate that ApoA-I synthesis and secretion are decreased during H2O2-induced oxidative stress in human hepatoma cell line HepG2. Here, we first show that FOXO1 binds to site B of apoA-I hepatic enhancer and downregulates apoA-I gene activity in HepG2 cells. Moreover, FOXO1 and LXRα transcription factors participate in H2O2-triggered downregulation of apoA-I gene together with Src, JNK, p38, and AMPK kinase cascades. Mutations of sites B or C as well as the administration of siRNAs against FOXO1 or LXRα to HepG2 cells abolished the hydrogen peroxide-mediated suppression of apoA-I gene.


Asunto(s)
Proteína Forkhead Box O1/metabolismo , Peróxido de Hidrógeno/toxicidad , Receptores X del Hígado/metabolismo , Estrés Oxidativo/efectos de los fármacos , Proteínas Quinasas Activadas por AMP/antagonistas & inhibidores , Proteínas Quinasas Activadas por AMP/genética , Proteínas Quinasas Activadas por AMP/metabolismo , Apolipoproteína A-I/genética , Apolipoproteína A-I/metabolismo , Regulación hacia Abajo/efectos de los fármacos , Proteína Forkhead Box O1/antagonistas & inhibidores , Proteína Forkhead Box O1/genética , Células Hep G2 , Humanos , Proteínas Quinasas JNK Activadas por Mitógenos/antagonistas & inhibidores , Proteínas Quinasas JNK Activadas por Mitógenos/metabolismo , Receptores X del Hígado/antagonistas & inhibidores , Receptores X del Hígado/genética , Inhibidores de Proteínas Quinasas/farmacología , Interferencia de ARN , ARN Interferente Pequeño/metabolismo , Regulación hacia Arriba/efectos de los fármacos , Proteínas Quinasas p38 Activadas por Mitógenos/antagonistas & inhibidores , Proteínas Quinasas p38 Activadas por Mitógenos/metabolismo , Familia-src Quinasas/antagonistas & inhibidores , Familia-src Quinasas/metabolismo
16.
J Cell Biochem ; 117(9): 2010-22, 2016 09.
Artículo en Inglés | MEDLINE | ID: mdl-26813964

RESUMEN

Apolipoprotein A-I (ApoA-I) is the main anti-atherogenic component of human high-density lipoproteins (HDL). ApoA-I gene expression is regulated by several nuclear receptors, which are the sensors for metabolic changes during development of cardiovascular diseases. Activation of nuclear receptor PPARγ has been shown to impact lipid metabolism as well as inflammation. Here, we have shown that synthetic PPARγ agonist GW1929 decreases both ApoA-I mRNA and protein levels in HepG2 cells and the effect of GW1929 on apoA-I gene transcription depends on PPARγ. PPARγ binds to the sites A and C within the hepatic enhancer of apoA-I gene and the negative regulation of apoA-I gene transcription by PPARγ appears to be realized via the site C (-134 to -119). Ligand activation of PPARγ leads to an increase of LXRß and a decrease of PPARα binding to the apoA-I gene hepatic enhancer in HepG2 cells. GW1929 abolishes the TNFα-mediated decrease of ApoA-I mRNA expression in both HepG2 and Caco-2 cells but does not block TNFα-mediated inhibition of ApoA-I protein secretion by HepG2 cells. These data demonstrate that complex of PPARγ with GW1929 is a negative regulator involved in the control of ApoA-I expression and secretion in human hepatocyte- and enterocyte-like cells. J. Cell. Biochem. 117: 2010-2022, 2016. © 2016 Wiley Periodicals, Inc.


Asunto(s)
Apolipoproteína A-I/biosíntesis , Regulación hacia Abajo , Elementos de Facilitación Genéticos , Enterocitos/metabolismo , Hepatocitos/metabolismo , PPAR gamma/metabolismo , Factor de Necrosis Tumoral alfa/metabolismo , Apolipoproteína A-I/genética , Benzofenonas/farmacología , Células CACO-2 , Células Hep G2 , Humanos , Receptores X del Hígado/genética , Receptores X del Hígado/metabolismo , PPAR alfa/genética , PPAR alfa/metabolismo , PPAR gamma/genética , Factor de Necrosis Tumoral alfa/genética , Tirosina/análogos & derivados , Tirosina/farmacología
17.
Artículo en Inglés | MEDLINE | ID: mdl-24674932

RESUMEN

Intra-mandibular localization of adenoid cystic carcinoma is rare. This tumor is characterized by progressive local, regional, and distant aggressiveness. We reviewed the latest data on this rare type of cancer with a small number of reported cases, alack of consensus for its treatment, and its bad prognosis.


Asunto(s)
Carcinoma Adenoide Quístico , Neoplasias Mandibulares , Adulto , Anciano , Anciano de 80 o más Años , Carcinoma Adenoide Quístico/diagnóstico , Carcinoma Adenoide Quístico/epidemiología , Carcinoma Adenoide Quístico/etiología , Carcinoma Adenoide Quístico/terapia , Femenino , Humanos , Masculino , Neoplasias Mandibulares/diagnóstico , Neoplasias Mandibulares/epidemiología , Neoplasias Mandibulares/etiología , Neoplasias Mandibulares/terapia , Persona de Mediana Edad , Radiografía Panorámica , Tomografía Computarizada por Rayos X , Adulto Joven
18.
Rev Stomatol Chir Maxillofac Chir Orale ; 114(5): 287-91, 2013 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-24176690

RESUMEN

INTRODUCTION: Bifocal fractures of the mandible often associate the angle and condyle or symphysis. Little data is available on biangular fractures. The authors had for aim to study their characteristics and to suggest an adapted management. MATERIAL AND METHODS: We retrospectively reviewed the records of patients operated on for a biangular fracture from January 2005 to December 2009. The impact of a third molar was evaluated using Pell and Gregory's and Shiller's classifications. RESULTS: Six hundred and forty patients underwent surgery for a mandibular fracture, seven of whom (1.1%) for biangular fractures. The patients' mean age was 27.6 years. Patients were predominantly men (85.7%). Assaults or brawls were the most frequent etiology (85.7%). The mechanism was direct impact in every case. The inferior alveolar nerve was injured in 57.1% of cases. There was an impacted third molar in 71.4% of cases. Most of the time, a single miniplate was sufficient for each angle. Two cases of postoperative infection were noted. The mean follow-up was 52.2months. The occlusion was restored in every case. Three patients presented with neurological sequels in the V3 area. DISCUSSION: Biangular fractures are rare and present a high risk of infection and neurological sequels. The presence of a mesioangular impacted third molar seems to be a predisposing factor. The risk of neurological sequels requires performing surgery rapidly.


Asunto(s)
Fracturas Mandibulares/epidemiología , Fracturas Mandibulares/cirugía , Adolescente , Adulto , Femenino , Humanos , Masculino , Fracturas Mandibulares/clasificación , Fracturas Mandibulares/complicaciones , Nervio Mandibular/cirugía , Persona de Mediana Edad , Tercer Molar/cirugía , Complicaciones Posoperatorias/epidemiología , Estudios Retrospectivos , Diente Impactado/complicaciones , Diente Impactado/epidemiología , Diente Impactado/cirugía , Traumatismos del Nervio Trigémino/complicaciones , Traumatismos del Nervio Trigémino/epidemiología , Traumatismos del Nervio Trigémino/cirugía , Adulto Joven
19.
Magn Reson Imaging ; 31(7): 1112-8, 2013 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-23727467

RESUMEN

Functional magnetic resonance imaging (fMRI) studies have shown dysfunction in key areas associated with the thalamocortical circuit in patients with schizophrenia. This study examined the functional connectivity involving the frontal-thalamic circuitry during a spatial focusing-of-attention task in 18 unmedicated patients with schizophrenia and 38 healthy controls. Functional connectivity was analyzed by assigning seed regions (in the thalamic nuclei (mediodorsal nucleus (MDN), pulvinar, anterior nucleus (AN)), the dorsolateral prefrontal cortex (Brodmann areas 9 and 46), and the caudate), and correlating their respective activity with that in the non-seed regions voxel-wise. Functional connectivity analysis demonstrated that functional connectivity was significantly impaired in patients, e.g., between the right pulvinar and regions such as the prefrontal and temporal cortices and the cerebellum. On the other hand, enhanced functional connectivity was found in patients, e.g., between the AN and regions such as the prefrontal and temporal cortices. In addition, the patients had significantly lower task performance and less (but non-significant) brain activation than those of controls. These results revealed disturbed functional integration in schizophrenia, and suggested that the functional connectivity abnormalities in the thalamocortical circuitry, especially the frontal-thalamic circuitry, may underlie the attention deficits in schizophrenia patients. Further, this study suggested that functional connectivity analysis might be more sensitive than brain activation analysis in detecting the functional abnormalities in schizophrenia.


Asunto(s)
Atención/fisiología , Imagen por Resonancia Magnética/métodos , Esquizofrenia/patología , Tálamo/patología , Adulto , Encéfalo/patología , Mapeo Encefálico/métodos , Corteza Cerebral/patología , Femenino , Humanos , Procesamiento de Imagen Asistido por Computador/métodos , Masculino , Plasticidad Neuronal , Esquizofrenia/fisiopatología , Sinapsis/patología , Adulto Joven
20.
Gene ; 524(2): 187-92, 2013 Jul 25.
Artículo en Inglés | MEDLINE | ID: mdl-23628799

RESUMEN

Complement C3 is involved in various protective and regulatory mechanisms of immune system. Recently it was established that C3 expression is regulated by nuclear receptors. Hepatic nuclear factor 4α (HNF4α) is a nuclear receptor critical for hepatic development and metabolism. We have shown that HNF4α is a positive regulator of C3 gene expression, realizing its effects through binding to two HNF4-response elements within the C3 promoter in HepG2 cells. TNFα is a well established positive regulator of C3 expression in hepatocytes during acute phase of inflammation. TNFα decreases the amount of HNF4α protein in HepG2 cells through NF-κB and MEK1/2 pathways thereby leading to a decrease in HNF4α bound to the C3 promoter. TNFα and HNF4α act in a synergetic way resulting in the potent activation of C3 transcription. These results suggest a novel mechanism of C3 regulation during acute phase response in HepG2 cells and display the mechanism of interaction of TNFα-induced pathways and HNF4α in transcriptional regulation of C3 gene.


Asunto(s)
Complemento C3/genética , Regulación de la Expresión Génica , Factor Nuclear 4 del Hepatocito/genética , Factor de Necrosis Tumoral alfa/inmunología , Complemento C3/inmunología , Complemento C3/metabolismo , Células Hep G2 , Factor Nuclear 4 del Hepatocito/inmunología , Factor Nuclear 4 del Hepatocito/metabolismo , Hepatocitos/efectos de los fármacos , Hepatocitos/inmunología , Hepatocitos/metabolismo , Humanos , Sistema de Señalización de MAP Quinasas , FN-kappa B/metabolismo , Regiones Promotoras Genéticas , Unión Proteica , Mapeo de Interacción de Proteínas , Activación Transcripcional , Factor de Necrosis Tumoral alfa/farmacología , Regulación hacia Arriba
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...